SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the September 2024 quarter moved up 29.27% to Rs. 900.34 millions as compared to Rs. 696.50 millions during the corresponding quarter last year.The company has announced a 35.57% increase in its profits to Rs . 84.84  millions for the  quarter ended September 2024 compared to Rs. 62.58 millions in the corresponding quarter in the previous year.Operating profit surged to 199.03 millions from the corresponding previous quarter of 154.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 900.34 696.50 29.27 1701.13 1371.00 24.08 3071.72 2509.95 22.38
Other Income 2.22 2.34 -5.13 5.00 6.30 -20.63 18.30 29.41 -37.78
PBIDT 199.03 154.99 28.41 375.38 297.02 26.38 684.63 632.29 8.28
Interest 27.07 24.11 12.28 51.85 45.96 12.82 103.87 60.20 72.54
PBDT 171.96 130.88 31.39 323.53 251.06 28.87 509.77 406.80 25.31
Depreciation 46.13 48.77 -5.41 86.32 96.56 -10.60 195.11 149.19 30.78
PBT 125.83 82.11 53.25 237.21 154.50 53.53 314.66 257.61 22.15
TAX 40.99 19.53 109.88 68.70 37.46 83.40 74.83 62.93 18.91
Deferred Tax 0.26 -1.96 -113.27 -0.06 -2.25 -97.33 -4.37 1.37 -418.98
PAT 84.84 62.58 35.57 168.51 117.04 43.98 239.83 194.68 23.19
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.11 22.25 -0.66 22.07 21.66 1.86 22.29 25.19 -11.52

Kwality Pharma Share Price

1676.00 -75.25 (-4.30%)
11-May-2026 10:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1873.90
Dr. Reddys Lab 1284.25
Cipla 1336.45
Zydus Lifesciences 939.05
Lupin 2251.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×